John Pye, the VP Global Offices & Innovation of $EXPO, sold 341 shares of the company on 02-10-2026 for an estimated $25,893. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.2% of their shares of this class of stock. Following this trade, they now own 28,863 shares of this class of $EXPO stock.
$EXPO Insider Trading Activity
$EXPO insiders have traded $EXPO stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $EXPO stock by insiders over the last 6 months:
- CATHERINE CORRIGAN (President & CEO) has made 0 purchases and 10 sales selling 24,519 shares for an estimated $1,714,010.
- JOHN PYE (VP Global Offices & Innovation) has made 0 purchases and 2 sales selling 4,000 shares for an estimated $303,897.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EXPO Hedge Fund Activity
We have seen 170 institutional investors add shares of $EXPO stock to their portfolio, and 222 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FUNDSMITH LLP removed 746,820 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $51,889,053
- POINT72 ASSET MANAGEMENT, L.P. added 471,025 shares (+inf%) to their portfolio in Q3 2025, for an estimated $32,726,817
- TWO SIGMA INVESTMENTS, LP added 428,616 shares (+inf%) to their portfolio in Q3 2025, for an estimated $29,780,239
- FIRST TRUST ADVISORS LP added 334,154 shares (+135.8%) to their portfolio in Q3 2025, for an estimated $23,217,019
- TWO SIGMA ADVISERS, LP added 329,800 shares (+inf%) to their portfolio in Q3 2025, for an estimated $22,914,504
- GW&K INVESTMENT MANAGEMENT, LLC removed 323,152 shares (-98.8%) from their portfolio in Q4 2025, for an estimated $22,446,137
- KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC removed 301,077 shares (-6.3%) from their portfolio in Q3 2025, for an estimated $20,918,829
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EXPO Revenue
$EXPO had revenues of $147.4M in Q4 2025. This is an increase of 7.79% from the same period in the prior year.
You can track EXPO financials on Quiver Quantitative's EXPO stock page.
$EXPO Congressional Stock Trading
Members of Congress have traded $EXPO stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $EXPO stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 09/11.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$EXPO Analyst Ratings
Wall Street analysts have issued reports on $EXPO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 11/17/2025
To track analyst ratings and price targets for $EXPO, check out Quiver Quantitative's $EXPO forecast page.
$EXPO Price Targets
Multiple analysts have issued price targets for $EXPO recently. We have seen 2 analysts offer price targets for $EXPO in the last 6 months, with a median target of $90.5.
Here are some recent targets:
- Tomohiko Sano from JP Morgan set a target price of $100.0 on 01/26/2026
- Joshua Chan from UBS set a target price of $81.0 on 12/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
